Growth promoting activity of Pangasianodon hypophthalmus recombinant

growth hormone expressed in Escherichia coli by Megarajan, Sekhar et al.
70Indian J. Fish., 62 (1): 70-77, 2015
Growth promoting activity of Pangasianodon hypophthalmus recombinant 
growth hormone expressed in Escherichia coli
MEGARAJAN SEKAR1, SHIVA DHAR SINGH2, RAYMOND JANI ANGEL3, DHARMENDRA 
KUMAR MEENA4, NACHIMUTHU SIVAKUMAR3, ESWARAN SURESH3 AND 
A. KATHIRVELPANDIAN5
1Regional Centre of Central Marine Fisheries Research Institute, Visakhapatnam - 530 003, Andhra Pradesh, India
2Indian Council of Agricultural Research (ICAR), KAB II, Pusa, New Delhi -110 012, India
3Central Institute of Fisheries Education, Panch Marg, Off Yari Road,  Andheri (W), Mumbai - 400 061, Maharashtra, India
4Central Inland Fisheries Research Institute, Barrackpore, Kolkata - 751 002, West Bengal, India
5National Bureau of Fish Genetic Resources Kochi Unit, Kochi - 682 018, Kerala, India
e-mail: sekarrajaqua@gmail.com
ABSTRACT
Recombinant growth hormone of Pangasianodon hypophthalmus (rPhGH) was efficiently expressed in Escherichia coli 
BL 21 (DE3) cells. The expression vector pET-32a(+) was used to clone and express a 550 bp long cDNA fragment, which 
encodes the mature region of growth hormone. The rPhGH was expressed as a 6X HIS-tag fusion protein in E. coli upon 
induction by Isopropyl b-D-thiogalactoside, and formed insoluble inclusion bodies in the host cells. SDS-PAGE analysis 
indicated that the molecular weight of the fusion protein was about 23 kDa, which is comparable to the theoretical value 
of the mature growth hormone of the fish. The expressed protein was recovered by solubilising the inclusion bodies under 
denaturing conditions with urea and then the denatured proteins were refolded and purified on Ni-NTA column. The purified 
recombinant protein was confirmed by Western blot analysis using anti-His antibodies. Total yield of the refolded and 
purified protein was 20 mg l-1 of LB medium. Biological activity of the purified recombinant protein was determined in 
in vivo bioassay by its ability to promote growth in rohu (Labeo rohita) fingerlings, injected with three different concentrations 
of the hormone. A significant increase in growth was observed in rohu fingerlings administered with rPhGH at a dosage of 
1.0 mg g body weight -1.
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Introduction
Fish contributes to food security in many regions of 
the world, providing a valuable supplement for diversified 
and nutritious diets (FAO, 2011). Over half of the aquatic 
species consumed is mainly produced from aquaculture 
and an estimate of additional 40 million t of aquatic 
food will be required by 2030 to meet the demand of 
increasing human population. At present, aquaculture 
contributes around 40% of the world fish production 
(FAO, 2013). However, the production is constrained 
mainly by the growth efficiency of cultured fish species. 
Growth rates of many fish species used in aquaculture 
are naturally slow, but are being enhanced by methods 
of domestication, nutritional approach, genetic selection, 
biotechnological as well as endocrinological approaches 
(Delvin et al., 2001). Endocrine approaches in controlling 
growth have been explored extensively through various 
means, principally by applications of somatotropins such 
as growth hormone (GH), prolaction, placental lactogen, 
insulin like growth factor-1 (IGF-1), thyroid hormones, 
and sex steroids (McLean and Delvin, 2000). A significant 
level of growth improvement has been achieved in fishes 
through application of these growth related hormones.
Fish growth hormone (GH) is produced by anterior 
pituitary cells and is involved in the regulation of growth, 
development, metabolism, appetite and osmoregulation 
in fishes (Silverstein et al., 2000). It is widely used to 
study feed intake efficiency and growth in different fishes. 
Growth hormone therapy is commonly used to enhance 
growth in domestic animals and it has become increasingly 
popular in aquaculture for finfishes and shellfishes (Ayson 
et al., 2000; Funkenstein, 2006; Linan-Cabello et al., 
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2013). Initially, mammalian growth hormone (GH) was 
found to accelerate the growth of fish and later, different 
approaches to accelerate  growth by administration of 
recombinant fish GH were explored and encouraging 
results have been reported in different fish species such 
as flounder (Jeh et al., 1998), giant catfish (Promodonkoy 
et al., 2004) and rabbit fish (Funkenstein et al., 2005). 
Recombinant DNA technology has revolutionised 
the biological science and recent advances in this field 
provide the means of large scale production of various 
recombinant proteins for commercial applications. Due 
to their effect on growth promotion, food conversion 
efficiency, and other physiological processes such as 
reproduction and osmoregulation (Farmanfarmaian and 
Sun, 1999), recombinant GHs have been demonstrated 
to have potential in agricultural and aquacultural 
applications. The fish recombinant growth hormone has 
been successfully produced from a large variety of species 
in different expression systems and currently used in 
aquaculture industry. Among these are the common carp, 
Indian major carp, tilapia, tuna, barramundi, rainbow 
trout, turbot, seabass and eel (Funkenstein, 2006). 
Pangasianodon hypophthalmus (sutchi catfish) is one of 
the fast growing catfish and popular fish species in some 
of the Asian countries (Khan et al., 2009). Its growth rate 
is influenced by many factors, among which the growth 
hormone may be one of the crucial factors playing role in 
fish growth similar to other vertebrate growth hormones 
(Promdonkoy et al., 2004). The present study was designed 
with an objective to produce recombinant growth hormone 
of P. hypophthalmus in Escherichia coli and to evaluate 
its biological activity in rohu (Labeo rohita) 
Materials and methods 
Experimental animal, bacterial strain, expression vector, 
template DNA and primers
Recombinant growth hormone of P. hypophthalmus 
(rPhGH) was produced and its biological activity was 
evaluated in 2 to 3 months old rohu (Labeo rohita) 
fingerlings, obtained from Kharland Research Station, 
Mumbai, India. Escherichia coli BL21 (DE3): F–ompT 
gal dcm lon hsdS B (rB
- mB
-) λ (DE3 [lacl lacUV5-T7 
gene I ind I sam7 nin5]) strain was used as host for expression 
of rPhGH. His-tag plasmid vector, pET-32a(+) (Novagen, 
USA) was selected as an expression vector for rPhGH 
expression. The recombinant plasmid containing the open 
reading frame (ORF) of P. hypophthalmus GH gene was 
constructed using pTZ57R/T cloning vector (Fermentas) 
and named as pTZ-PhGH. This gene construct was 
developed in our earlier experiment and the gene sequence 
of ORF region has been submitted in NCBI GenBank 
under the accession number GQ859589. The developed 
recombinant plasmid (pTZ-PhGH) was used as template 
for PCR amplification of cDNA fragment encoding the 
mature PhGH. The primer set used for amplification of 
cDNA encoding mature PhGH was designed, using the 
gene sequence in the cDNA sequences of PhGH gene 
(NCBI GenBank: GQ859589). The primer sequences 
designed are follows: forward: 5’-AAAGAATTCATTC 
GAGAACCAGCGGCTCTTC-3’, and reverse: 5’-AA 
AAAGCTTCAGGGTGCAGTTGGAATCCAG-3’ with 
EcoRI and HindIII restriction enzyme sites (underlined 
nucleotides) at 5’ end, respectively.
Construction of recombinant expression vector for PhGH 
expression 
The cDNA fragment encoding mature PhGH was 
obtained by PCR amplification with specific forward 
and reverse primers. The PCR reaction was performed 
for an initial denaturation at 94oC for 5 min, 30 cycles 
of denaturation at 94oC for 50s, annealing at 59oC for 
60s and extension at 72oC for 2 min and then finally a 
single cycle of final extension at 72oC for 10 min. The 
amplified fragment was digested with EcoRI and HindIII 
restriction enzymes and then cloned into the same 
enzyme site in the multiple cloning sites of pET-32a(+) 
vector. The constructed plasmid was denominated with 
pET-PhGH and transformed into competent cells of E. coli 
BL21 (DE3) for expression of fusion protein. The 
transformed cells were selected on LB agar plates 
containing ampicillin (100 mg ml-1) and chloramphenicol 
(25 mg ml-1) and further the recombinant plasmid was 
reconfirmed by restriction enzyme analysis with EcoRI 
and HindIII. The positive colonies growing on the plates 
were selected and used for the expression. 
Expression of recombinant PhGH and SDS-PAGE 
analysis
The transformed E. coli BL21 (DE3) cells containing 
pET-PhGH were grown overnight at 37oC in LB medium 
containing 100 mg ml-1 of ampicillin and 25 mg ml-1 of 
chloramphenicol. Fresh LB broth with 100 mg ml-1 
of ampicillin was inoculated with the non-induced 
overnight culture. The culture was further grown at 37oC 
with vigorous shaking until the growth reached mid log 
phase (OD
600
 of 0.6) and was induced with 1 mM IPTG 
(Isopropyl b-D-thiogalactoside) (Sigma, USA). The 
induced culture was grown for another 5-6 h and harvested 
by centrifugation at 4000 g for 20 min at 4oC. The 
harvested cell pellet was washed with phosphate buffered 
saline (PBS) and dissolved in non-denaturing lysis buffer 
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(50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH. 8). 
The cells in the buffer were subjected to freeze thawing 
once and then centrifuged at 4000 g for 20 min at room 
temperature. The supernatant solution was collected and 
marked as soluble fraction and then the pellet containing 
insoluble fraction was resuspended in appropriate volume 
of 2X SDS-PAGE sample buffer (0.09 M Tris·Cl, pH 
6.8; 20% glycerol; 2% SDS; 0.02% bromophenol blue; 
0.1 M DTT), and boiled at 100oC for 5 min, then cell pellet 
lysate was collected after centrifugation. The supernatant 
of soluble fraction and cell pellet lysate were analysed 
for recombinant protein expression and its solubility on 
12.5% SDS polyacrylamide gel electrophoresis (SDS-
PAGE) along with the uninduced bacterial cell lysate as 
control.
Purification and refolding of recombinant PhGH
For recombinant protein purification, the induced 
cells were cultured in 250 ml flask and pelleted by 
centrifugation at 4000 g for 20 min, and then the pellet 
was resuspended in 8 ml of cell lysis buffer (100 mM 
NaH2PO4, 10 mM Tris-HCl, 8 M urea, pH 8). Cells 
in lysis buffer were lysed by sonication on ice, and the 
cell lysate was centrifuged at 6000 g for 20 min at room 
temperature to pellet the cell debris. The supernatant 
was separated and mixed with nickel-nitrilotriacetic acid 
(Ni-NTA) agarose (Qiagen, Germany) at a ratio of 4:1, 
and then the mixture was vigorously mixed at 200 rpm for 
1 h. The lysate-resin mixture was loaded into an empty 
column with attached bottom cap and incubated for 2 h 
at room temperature. Then, the column with protein was 
shifted to 16oC and the unbound protein was collected as 
flow through after removing the bottom cap. The Ni-NTA 
column based refolding and purification was performed 
as per procedure followed by Saini et al. (2002). In this, 
the column was washed with denaturing buffer containing 
20 mM  imidazole and then washed stepwise with 
decreasing concentration of urea (6 - 1 M) in refolding buffer 
(20 mM Tris HCl, pH 8.0, 500 mM NaCl, 10% glycerol, 
20 mM imidazole, 0.5 mM oxidized glutathione (GSSG) 
and 5 mM reduced glutathione (GSH)). Then again, 
the column was washed with refolding buffer without 
urea to remove contaminating E. coli proteins. The 
bound protein was eluted with 5 ml of refolding buffer 
containing 250 mM of imidazole in  fractions of 1 ml. 
All the fractions were analysed in SDS-PAGE, then the 
peak fractions were pooled and dialysed against storage 
buffer (50 mM Tris-HCl, pH 8.0, 50 mM NaCl, 50% 
glycerol, 0.1 mM DTT) and stored at 4 oC overnight. After 
dialysis, the protein was analysed in SDS-PAGE for its 
refolding and purity. Western blot analysis of purified 
protein was carried out by QIA express detection and 
assay kit (Qiagen, Germany) based on manufacturer’s 
protocol. The protein was detected using HRP 
conjugated anti-histidine antibody (Qiagen, Germany). 
The concentration of purified and refolded recombinant 
GH was determined by Bicinchonic Acid (BCA) method 
with bovine serum albumin (BSA) as the standard using a 
protein estimation kit (Bangalore Genei, India). Standard 
was prepared as per the manufacturer’s instructions.
Determining biological activity of recombinant PhGH
The growth promoting activity of purified and 
refolded rPhGH was tested in vivo with 2 to 3 months old 
rohu (Labeo rohita) fingerlings. A total of 240 fingerlings 
were randomly divided in to four different groups of 
20 fishes per group, namely control and three treatments 
(T1, T2 and T3) with three replicates, and all the treatment 
groups were stocked in 500 l capacity FRP tanks. The 
rPhGH was diluted in biological saline (0.85% NaCl) and 
administered at dosages of 0.25, 0.5 and 1 mg g-1 body 
weight of fingerlings for T1, T2 and T3, respectively. The 
injections were given once in a week for four weeks, by 
intramuscular injection. The dosage was determined based 
on the data provided by previous studies (Silverstein et al., 
2000). The entire experiment was carried out for 12 weeks 
and fishes in each group were weighed individually, once 
in a week for 12 weeks. During the experiment, all the 
fishes were fed with commercial feed twice  a day at 5 to 
7% of total body weight. Water quality was maintained 
within the safe limits for the species for all the groups 
and water exchange was done periodically as and when 
required. 
Statistical analysis
One way analysis of variance (ANOVA) was 
performed using SPSS statistical software package (SPSS 
version 15, USA). All the data were subjected to one way 
ANOVA and Duncan’s multiple range tests (Duncan, 
1955) to determine the differences in means (p≤ 0.05). 
The mean of 20 observations per group with replicates 
was used for growth analysis. All parametric data are 
expressed as mean ± SE. 
Results
Expression of recombinant PhGH in E. coli
The cDNA fragment encoding  mature PhGH was 
PCR amplified from the pTZ-PhGH recombinant plasmid 
and was inserted into the pET-32a(+) expression vector 
to obtain the pET-PhGH (Fig. 1) plasmid construct with 
an aim of obtaining  E. coli BL21 (DE3) strain producing 
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intracellular PhGH protein. Recombinant growth hormone 
was expressed in transformed E. coli BL21 culture after 
induction with 1 mM of IPTG. The expression of rPhGH 
was confirmed in SDS-PAGE by observing the presence of 
a distinct band corresponding to the estimated rPhGH size 
of about 23 kDa (Fig. 2a). The distinct band of particular 
size was found in cell lysate of induced E. coli cells 
containing recombinant plasmid. However, the same band 
was absent in uninduced transformed E. coli cells, which 
confirmed the expression of the recombinant protein after 
induction. Further, the solubility of the expressed protein 
was analysed in SDS-PAGE, in which the supernatant 
of cell lysis buffer  was marked as soluble fraction and 
cell pellet lysate obtained after boiling was marked as 
insoluble fractions, and both the fractions were analysed 
on SDS-PAGE. The recombinant protein was found only 
in an insoluble fraction and was absent in soluble fraction. 
The protein solubility analysis revealed that the rPhGH 
was expressed at high levels but confined exclusively to 
the insoluble fraction as inclusion bodies. 
Purification and matrix assisted refolding of PhGH
The recombinant fusion PhGH expressed as 
inclusion bodies was solubilised using sonication in cell 
lysis buffer containing strong denaturing agent (8M urea). 
SDS-PAGE analysis of the solubilised protein indicated 
that the protein was expressed along with several 
cellular proteins of E. coli, which is evidenced by the 
presence of many bands along with the targeted protein 
(Fig. 2a). The recombinant fusion PhGH was purified from 
E. coli under denaturing conditions using Ni-NTA column 
along with other several cellular proteins. The denatured 
fusion protein was simultaneously renatured using matrix 
assisted refolding method and purified from other cellular 
proteins. While purification, five different fractions were 
collected and analysed in SDS-PAGE (data not shown) 
and among all, the fractions 3-5 were identified as peak 
fractions. All the peak fractions of purified proteins were 
dialysed after pooling and a total of 10 ml of elute was 
recovered after dialysis. SDS-PAGE analysis of dialysis-
purified protein showed a single band with the expected 
molecular weight of about 23 kDa (Fig. 2b). The presence 
Fig 1. Restriction enzyme digestion of recombinant plasmid (pET 
 PhGH) containing pET-32a expression vector and the gene 
 encoding mature region of PhGH
 Lane M1: Molecular weight marker (500 bp DNA ladder up to 
 5 kb); Lane 1: The expected PhGH gene insert (550 bp) released after 
 digestion with EcoRI & HindIII; Lane 2: Recombinant plasmid 
 with PhGH gene insert (~6.4 kb); Lane 3: EcoRI & HindIII digest 
 of control pET-32a plasmid (5.9 kb);  Lane 4: Uncut control 
 plasmid (5.9 kb); Lane M2: Molecular weight marker (100 bp)  
 DNA ladder up to 3 kb
6.4 kb
5 kb 5.9 kb
500 bp
1 kb
550 bp
M1      1       2       3         4    M2
43.0 kD
29.0 kD
20.1 kD
14.3 kD
6.5 kD
43.0 kD
29.0 kD
20.1 kD
14.3 kD
6.5 kD
~23.0 kD ~23.0 kD
M          1           2           M
M       1          2       3        4          5        M 
                                                           (a)                                                                                                                   (b)
Fig. 2. Expression and purification of recombinant PhGH
 (a) Expression of recombinant growth hormone of P. hypophthalmus in E. coli. Lane M: Protein molecular weight markers; 
 Lane 1: Cell lysate from un-induced cells (control); Lane 2: Induced cells expressed recombinant PhGH with molecular weight of ~23.0 kDa 
 (b) Purification of recombinant PhGH by Ni-NTA agarose column. Lane M: Protein molecular weight markers; Lane 1: Cell lysate; 
 Lanes 2-4: Wash; Lane 5: Elutes (Purified and refolded recombinant PhGH after dialysis).
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of a single protein band confirmed that the protein was 
purified and properly refolded in the column. Western 
blot analysis of the purified protein from the 12.5% 
SDS-PAGE under reducing condition showed that the 
protein was immunoreactive to an anti-His antibody. The 
observed molecular weight of the protein was ~23 kDa 
(Fig. 3), which is identical to an estimated size of the 
protein and  confirmed that the expressed and purified 
protein was PhGH. The concentration of the purified 
protein was estimated as 520 mg ml-1 and the estimated 
total concentration of purified protein was 20 mg l-1 from 
250 ml of E. coli broth culture.
Fig. 4. Biological activity of PhGH. Graphical representation of 
 mean ± standard error (n = 20) for initial and final average 
 weight of the fish treated with different dosage of purified rPhGH 
 per g body weight of L. rohita
Treatments       
Week
   Control        T1        T2       T3
1 14.42±0.40 14.55±0.32 13.92±0.56 14.91±0.26
2 14.66±0.11 15.07±0.17 14.86±0.23 15.77±0.08
3 15.06a±0.38 15.41a±0.16 15.38a±0.17 16.73b±0.14
4 15.21a±0.11 15.64b±0.07 15.69b±0.09 17.14c±0.06
5 15.50a±0.18 16.01a±0.15 15.91a±0.07 17.56b±0.19
6 15.73a±0.21 16.26a±0.11 16.13a±0.09 18.34b±0.18
7 16.06a±0.1 16.66b±0.09 16.40b±0.07 18.75c±0.08
8 16.15a±0.22 17.06b±0.24 16.76b±0.02 19.50c±0.05
9 16.98a±0.20 17.98b±0.13 17.43ab±0.21 20.41c±0.08
10 17.56a±0.18 18.67b±0.07 18.19ab±0.31 21.50c±0.28
11 18.42a±0.13 19.20b±0.25 19.54b±0.19 22.70c±0.06
12 19.12a±0.05 19.97b±0.11 21.27c±0.12 24.30d±0.18
43.0 kD
29.0 kD
~ 23.0 kD
20.1 kD
14.0 kD
~23.0 kD
1              2             M 
Fig. 3. Western blot analysis of purified recombinant growth hormone 
 with anti His antibodies. Lane 1: Purified PhGH after western 
 blot; Lane 2: Purified PhGH after SDS-PAGE (control); Lane M: 
 Protein molecular weight markers
Determining biological activity of  rPhGH
The biological activity of the recombinant PhGH was 
assessed in in-vivo bioassay by measuring the differential 
weight gain in the fishes injected with recombinant growth 
hormone and control. The average weight gain of fishes in 
control and treatments (T1, T2 and T3) were 4.7, 5.42, 7.35 
and 9.39 g and the average initial and final weight were 
14.42, 14.55, 13.92, 14.91 and 19.12, 19.97, 21.27, 24.30 g 
respectively (Fig. 4). Among the treatment groups, the 
maximum growth was observed for T3 administered with 
1.0 mg g-1 body weight of the hormone.  The mean, standard 
error and differences in weight gain for the weekly growth 
were calculated by one way ANOVA (Table 1). From 
the analysis, it is observed that treatment 3 (T3) showed 
significant differences in growth gain when compared to 
control, and other treatment (T1 and T2) groups from third 
week onwards. The weight gain between the T1 and T2 
groups did not show any significant difference. However, 
these two treatments showed significant difference 
(p≤0.05) with control. The cumulative weight gain in the 
third month (4.8 g) was observed to be significantly high 
Control     0.25 µg        0.5 µg       1.0 µg
Treatments
30
25
20
15
10
5
0
B
od
y 
w
ei
gh
t (
g)
Initial weight
Final weight
Table 1. Biological activity of Pangasianodon hypophthalmus growth 
 hormone (PhGH)
(p≤0.05) when compared to the cumulative weight gain of 
first (2.23 g) and second (2.36 g) months of fish injected 
with 1.0 mg g-1 body weight of the hormone. 
Discussion
Enhancing growth of farmed fish using recombinant 
growth hormone can be achieved by different methods of 
delivery viz., injection, diet, osmotic shock and immersion 
(Funkenstein, 2006). Growth hormone gene in a large 
variety of fish species has been cloned, expressed and 
the recombinant protein has been used in aquaculture 
industry. Among these are the tuna (Kimura, 1991), Indian 
major carps (Venugopal et al., 2002), gold fish (Chan 
et al., 2003), common carp (Li et al., 2003), giant catfish 
(Promdonkoy et al., 2004) and flounder (Zang et al., 
2007). But, the effective utilisation of recombinant fish 
growth hormone in aquaculture  depends on biological 
activity of the hormone. Biologically active recombinant 
fish growth hormone has been successfully produced in 
E. coli, Saccharomyces cerevisiae, Pichia pastoris and the 
microalgae Chlorella ellipsoidea and Synechocystis sp. 
(Zang et al., 2007).
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In the present work, we have cloned a 550 bp long 
cDNA encoding mature GH of P. hypophthalmus (PhGH) 
and expressed in E. coli host. The size of the recombinant 
fusion protein (PhGH) produced was about 23 kDa, 
including the 6X His tag (approx. 1.6 kDa) and hence, the 
original polypeptide constituting the functional hormone 
is of about 21.5 kDa consisting of 200 amino acids. The 
fusion rPhGH was expressed after induction and resulted in 
accumulation and aggregation as inclusion bodies, which 
is a common phenomenon for over expressed or bacterial 
recombinant proteins having disulfide bonds (Sciara 
et al., 2006). Thus, to isolate the protein from inclusion 
bodies and to produce native conformation, the strategy 
of denaturaion, renaturation and folding was used. After 
renaturation and folding, the total estimated concentration 
of the protein was about 20 mg l-1 of E. coli culture. The 
concentration of the expressed protein is lower than the 
GH expressed from several fishes, including 150 mg l-1 of 
Pangasianodon gigas rGH in E. coli (Promdonkoy et al., 
2004), 200 mg l-1 of carp and 100 mg l-1 of Lateolabrox 
japonicus growth hormone in P.  pastoris (Caelers et al., 
2005). However, a proportionately low level expression 
of recombinant protein to cellular protein in E. coli cells 
was also reported in eel (5%), rainbow trout (7.7%), chum 
salmon (15%) and tilapia (20%) (Tsai et al., 1995). The 
observed lower protein concentrations in the study might 
be due to the formation of insoluble inclusion bodies and 
loss during purification. 
The in vivo assay for testing the biological activity 
of rPhGH indicated that the fish injected with 1.0 mg g-1 
body weight (T3) grew faster than the control and other 
two treatment groups, injected with 0.25 and 0.5 mg g-1 
body weight (T1 and T2). Overall growth performance 
among the treatments showed significant difference 
(p<0.05), with weight gain in T3 being significantly 
higher (p<0.05) than that of T1, T2 and control group. 
This significant difference was observed after two weeks 
of injection, which implies that the growth hormone 
would not promote the growth directly but may require 
other intermediate factors to introduce its functions. In 
accordance with our study, biological activity of Cyprinus 
carpio (Fine et al., 1993) and Paralichthys olivaceus 
(Zang et al., 2007) growth hormones showed significantly 
higher growth differences between control and treatments. 
On the contrary, Promdonkoy et al. (2004)  observed that 
administration of 0.1 mg of P. gigas GH showed faster 
growth than control but the difference was  not statistically 
significant. 
In the present study, growth stimulating effect of 
rPhGH on rohu (L. rohita) fingerlings was observed, 
which is in agreement with the  results of several authors 
viz.,  Sugimoto et al. (1990); Fine et al. (1993); Jeh 
et al. (1998); Promdonkoy et al. (2004); Sciara et al. 
(2011) and Linan-Cabello et al. (2013), who observed the 
growth promoting effect of recombinant growth hormone 
of eel, common carp, flounder, giant catfish, pejerrey and 
nile tilapia, respectively. Although the recombinant growth 
hormone of several fishes showed biological activity,  the 
optimum concentration required to enhance the growth 
varies among the fish species. Therefore, in the present 
study,  three different concentrations were studied to know 
the optimum concentration of rPhGH for stimulating 
growth of fish, and it was observed that the weight gain 
of fish treated with 1 mg g-1 was higher than the weight 
gain when treated with 0.25 and 0.5 mg g-1 body weight. 
Therefore, the results suggest that high concentration of 
rPhGH is required for stimulating the biological activity. 
Similarly, the requirement of higher dose of recombinant 
growth hormones were also observed by Wilson et al. 
(1988), who reported  that fish which received 10 µg g-1 
of recombinant growth hormone showed faster growth. 
Li et al. (2003) observed the weight of tilapia injected 
with 1 µg g-1 of growth hormone was higher than the fish 
injected with 0.1 µg g-1 and similarly, cinnamon clownfish 
injected with 1 µg g-1 body weight of rGH showed 
increased body length, when compared to 0.1 µg g-1 of 
hormone (Kim et al., 2014). However, some of the earlier 
studies  also observed that higher dose of recombinant 
growth hormone treatments have less effect on growth 
enhancement. Adverse effect caused by higher dose of 
rGH were reported by Tsi et al. (1995), who observed  that 
the weight gain of fish treated with 1 µg g-1 was less than 
that of the fish treated with 0.1 µg g-1. Promdonkoy et al. 
(2004) observed that the optimum level of catfish GH to 
increase growth of gold fish should be less than 1 µg g-1 of 
fish body weight. Results of different studies indicate that 
the growth promoting potential of recombinant fish growth 
hormone varies among different fish species. However, 
in addition to the species specific action, the growth 
promoting effect of recombinant hormone may also be 
determined by fish growth physiology, binding capacity 
between GH and growth hormone receptors and potency 
of the hormone. Results of the present study has shown 
that the biologically active recombinant catfish growth 
hormone can be efficiently produced using pET-32a(+) 
expression vector in E. coli, and it  promoted  growth of 
rohu fingerlings at the concentration of 1 µg g-1 of fish body 
weight. Many investigators have demonstrated that the 
administration of exogenous recombinant growth hormone 
as a feed supplement could be a viable method to enhance 
growth rate of cultured fish. However, limitations such as 
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formation of inclusion bodies and need for purification of 
proteins by a complicated procedure before use restrict 
its wider application (Friesh and Reardon, 1993). Use 
of appropriate vectors for extracellular expression of 
recombinant growth hormone in a probiotic bacterium 
may help to avoid the complicated purification process. 
Further, use of nanotechnological approaches for efficient 
delivery of exogenously produced recombinant fish GH 
may help in effective use of the protein for enhancing fish 
growth in  commercial aquaculture. 
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